Results 1 to 10 of about 261,124 (307)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

Cells, 2022
Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a century, and, nowadays, physicians possess a broad panel of multiple ...
Geraldine Poenou, Fabrice Cognasse, Laurent Bertoletti   +2 more
exaly   +4 more sources

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Background Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded)
Emmanuel J. Favaloro, Leonardo Pasalic
doaj   +3 more sources

Anticoagulants and Osteoporosis [PDF]

International Journal of Molecular Sciences, 2019
Anticoagulant agents are widely used in the treatment of thromboembolic events and in stroke prevention. Data about their effects on bone tissue are in some cases limited or inconsistent (oral anti-vitamin K agents), and in others are sufficiently strong
S. Signorelli, Salvatore Scuto, Elisa Marino, M. Giusti, A. Xourafa, A. Gaudio   +5 more
semanticscholar   +3 more sources

A Study of Using Anticoagulants in a Tertiary Care Hospital in Bangalore: A Prospective Study [PDF]

Journal of Health Sciences and Surveillance System, 2021
Background: drug utilization studies are necessary to evaluate the rational use and associated risks of anticoagulants. This study aimed to identify drug utilization pattern and possible drug interactions with the use of anticoagulants in a tertiary care
Shahrzad Raouf, Farshad Namdarifar, Emad Malekpour Shahraki, Sridhara Murthy   +3 more
doaj   +1 more source

Anticoagulant therapy post-COVID in the perioperative setting: Bountiful of choices, indefinite treatment plans- A case report

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
A post-COVID patient with a high D-dimer Value (>5000 IU) was posted for total knee replacement. She was on multiple anticoagulants including the novel oral anticoagulants that started to reduce thrombotic risk.
Balasubramaniam Gayathri, Karthik Krishnamoorthy, Chandrakanth Lakshmikanthan, M Yuvashree   +3 more
doaj   +1 more source

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs

Российский кардиологический журнал, 2021
The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj   +1 more source

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

JAMA Neurology, 2023
Key Points Question Is the recent use of direct oral anticoagulants (confirmed ingestion within 48 hours) associated with increased risk of symptomatic intracranial hemorrhage following intravenous thrombolysis for ischemic stroke?
T. Meinel, D. Wilson, H. Gensicke, J. Scheitz, P. Ringleb, I. Goganau, J. Kaesmacher, H. Bae, D. Y. Kim, P. Kermer, Kentaro Suzuki, K. Kimura, Kosmas Macha, M. Koga, S. Wada, V. Altersberger, A. Salerno, L. Palanikumar, A. Zini, S. Forlivesi, L. Kellert, J. Wischmann, E. Kristoffersen, James Beharry, P. Barber, Jae-Beom Hong, C. Cereda, E. Schlemm, Y. Yakushiji, S. Poli, R. Leker, M. Romoli, M. Zedde, Sami Curtze, B. Ikenberg, T. Uphaus, D. Giannandrea, P. Portela, R. Veltkamp, A. Ranta, M. Arnold, U. Fischer, J. Cha, Teddy Y. Wu, J. Purrucker, D. Seiffge, M. Goeldlin, B. Siepen, M. Mueller, M. Beyeler, A. Scutelnic, Simon Jung, A. Mujanović, C. Kurmann, T. Dobrocky, Eike Piechoviak, R. Wiest, A. Hakim, P. Bücke, Ž. Jana, Lichti Carmen, Dmytrow Diana Isabella, J. Ramos, D. Strambo, Menuela Buehrer, N. Simaan, A. Honig, A. Filioglo, I. Grisendi, Laura Ferri, M. Trapasso, Matteo Benini, R. Pascarella, Claudio Moratti, M. Napoli, S. Sumaria, K. Gröschel, M. Hahn, A. Polymeris, C. Traenka, Annaelle Zietz, P. Lyrer, G. M. DeMarchis, S. Thilemann, Ines Piot, L. Enz, N. Peters, M. Katan, A. Brehm, M. Psychogios, Ulrike Prange, N. Spratt, Laurent Roten, B. Chew, Jakub Stefela, R. von Rennenberg, S. Litmeier, Christoph Riegler, M. Klammer, H. Erdur, Hellwig Simon, M. Mauro, L. Marco, Cordici Francesco, B. Sara, Peter Tan, M. Ercegovac, I. Berisavac, D. Haupenthal, L. Gassmann, Armin Marsch, Gabriela Siedler, L. Weir, L. Pesavento, N. Yassi, Stephen Davis, B. Ip, T. Leung, Alexandra Gomez-Exposito, J. Mbroh, J. Tünnerhoff, G. Barbu, Yi Wang, Annerose Mengel, Feil Katharina, M. Kowarik, U. Ziemann, J. Kim, Jihoon Kang, Moon‐Ku Han, B. Kim, K. Choi, Man-Seok Park, Ki-Hyun Cho, J. Kim, Dong-Ick Shin, K. Yum, Dae-Hyun Kim, J. Cha, Jong-Moo Park, K. Kang, Yong Soo Kim, J. Kim, S. Lee, M. Oh, Byung‐Chul Lee, M. Lee, K. Yu, Hong‐Kyun Park, K. Hong, Yong‐Jin Cho, J. Choi, Joong-Goo Kim, Chul-Hoo Kang, S. Sohn, Jeong‐Ho Hong, S. Jang, Hyungjong Park, T. Park, Sang-Soon Park, K. Lee, J. Kwon, Wook-Joo Kim, J. Lee, D. Kwon, Dong-Seok Gwak, Dong-Eog Kim, K. Lee, Sang-Hwa Lee, Chulho Kim, H. Jeong, K. Park, J. S. Lee, Juneyoung Lee, N. Martinez-Majander, G. Sibolt, M. Tiainen, M. Gentile, L. Migliaccio, L. Simonetti, M. Paolucci, Alan Flores, L. Seró, G. Turc, C. Oppenheim, O. Naggara, W. Ben Hassen, J. Benzakoun, Y. Yakushiji, T. Kunieda, G. Kägi, S. Engelter, C. Nolte, B. Kallmünzer, P. Michel, T. Kleinig, J. Fink, O. Rønning, B. Campbell, P. Nederkoorn, G. Thomalla, T. Kunieda, Khouloud Poli, Y. Béjot, Y. Soo, C. Garcia-Esperon, G. Ntaios, C. Cordonnier, J. Marto, G. Bigliardi, François Lun, P. Choi, T. Steiner, X. Ustrell, D. Werring, S. Wegener, A. Pezzini, Houwei Du, J. Martí-Fábregas, D. Cánovas-Vergé, D. Strbian, V. Padjen, S. Yaghi, C. Stretz, J. Kim   +224 more
semanticscholar   +1 more source

IMPACT OF NON-VITAMIN K ORAL ANTI-COAGULANTS ON WARFARIN UTILISATION AND NHS BUDGET IN UK

Global Journal of Public Health Medicine, 2022
Introduction: Vitamin K anticoagulants were the mainstay prophylaxis of stroke in patients with atrial fibrillation and thromboembolic diseases. Non-vitamin K oral anticoagulants were approved for use in UK.
Mohammed Aladul, Raymond Fitzpatrick, Stephen Chapman   +2 more
doaj   +1 more source

Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation [PDF]

Journal of Neurocritical Care, 2023
Background Optimal anticoagulation therapy reduces the risk of ischemic stroke in patients with nonvalvular atrial fibrillation (AF). Therefore, we aimed to evaluate the effects of prior anticoagulation therapy with vitamin K antagonists (VKAs) and ...
Tae Jung Kim, Soo-Hyun Park, Youngjoon Kim, Sang-Bae Ko   +3 more
doaj   +1 more source

Anticoagulants for people hospitalised with COVID-19.

Cochrane Database of Systematic Reviews, 2022
BACKGROUND The primary manifestation of coronavirus disease 2019 (COVID-19) is respiratory insufficiency that can also be related to diffuse pulmonary microthrombosis and thromboembolic events, such as pulmonary embolism, deep vein thrombosis, or ...
Ronald Lg Flumignan, V. T. Civile, J. D. D. S. Tinôco, P. I. Pascoal, L. L. Areias, C. Matar, B. Tendal, Virgínia FM Trevisani, Á. Atallah, L. C. Nakano   +9 more
semanticscholar   +1 more source